18 results
PRE 14A
LRMR
Larimar Therapeutics Inc
12 Apr 24
Preliminary proxy
6:06am
responsibility for the risk management process, including monitoring and assessing strategic risk exposure, its Committees oversee risk in certain … and avoiding litigation abuse resulting from the current disparity that exists in the treatment of directors, who oversee and are ultimately accountable
8-K
EX-1.1
LRMR
Larimar Therapeutics Inc
16 Feb 24
Entry into a Material Definitive Agreement
4:06pm
(“Exchange Rules”), validly appointed an audit committee to oversee internal accounting controls whose composition satisfies the applicable requirements
8-K
EX-1.1
th79y
14 Sep 22
Entry into a Material Definitive Agreement
9:01am
8-K
EX-10.3
3jnqq81hc
21 May 21
Entry into a Material Definitive Agreement
9:30am
8-K
EX-10.2
ieaxc17j v7dh1561buj
21 May 21
Entry into a Material Definitive Agreement
9:30am
8-K
EX-10.2
kkqws goysqm8u
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
DEFM14A
u62bo 16drg
29 Apr 20
Proxy related to merger
3:20pm
PRER14A
m5h751lcqqpzho
10 Apr 20
Preliminary revised proxy
4:38pm
PREM14A
yblthmj
6 Mar 20
Preliminary proxy related to merger
5:32pm
- Prev
- 1
- Next